Odile Launay - Concepedia

Author

Odile Launay

Also Known As

A. S. Lascaux, Alexis Jacquet, B Elharrar, Clarisse Loyer, Delphine Lariviere, L Guillevin, Launay Odile, Launay, O, Launay, Odile, Louis Bernard

571

Publications

13.6K

Citations

H-Index

164

Concepts

All Affiliations

Université Paris Cité Inserm Assistance Publique – Hôpitaux de Paris Hôpital Cochin Délégation Paris 5

About

Odile Launay is an author at Université Paris Cité specializing in medicine, vaccination, and vaccine efficacy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	79	4.5K
2	Public Health	24	35	1.7K
3	Health Sciences	2	2	187
4	Arts	1	1	98
5	Education	1	1	98

Odile Launay

187

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial Jean-Louis Bresson, Christian Perronne, Odile Launay, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyInfluenza Vaccine	2006	412
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study Françoise Dromer, Simone Mathoulin‐Pélissier, Odile Launay, PLoS Medicine	2007	376
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites, The Lancet Infectious Diseases	2021	338
Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France Pierre Verger, Lisa Fressard, Fanny Collange, EBioMedicine	2015	332
Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness Ann R. Falsey, Janet E. McElhaney, Gerrit A. van Essen, The Journal of Infectious Diseases	2014	284
Mucosal Imprinting of Vaccine-Induced CD8 <sup>+</sup> T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors Federico Sandoval, Magali Terme, Mevyn Nizard, Science Translational Medicine	2013	222
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 Odile Launay JAMA	2011	177
Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations Pierre Loulergue, Flore Moulin, G. Vidal-Trécan, Vaccine VaccinologyVaccine SafetyVaccinationPreventive MedicineWorkplace Health Surveillance	2009	167
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyTwo-dose Heterologous Ad26.zebovVaccine Surveillance	2020	164
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial Janet E. McElhaney, Jeanne‐Marie Devaster, Meral Esen, The Lancet Infectious Diseases VaccinationVaccine SafetyCross-protectionVaccinologyElderly People	2013	161

Page 1